CURE vs. NBIG

Last updated Jun 5, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and NBIG (Leverage Shares 2X Long NBIS Daily ETF) are both Leveraged Equities funds. CURE is passively managed, while NBIG is actively managed. At a 0.04 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.75%/yr for NBIG.

Performance

CURE vs. NBIG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Leverage Shares 2X Long NBIS Daily ETF (NBIG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CURE achieves a -10.92% return, which is significantly lower than NBIG's 487.61% return.

CURE

• 1D: 9.14%
• 1M: 12.73%
• YTD: -10.92%
• 6M: -9.12%
• 1Y: 31.64%
• 3Y*: 2.38%
• 5Y*: 1.98%
• 10Y*: 12.46%

NBIG

• 1D: 6.23%
• 1M: 96.57%
• YTD: 487.61%
• 6M: 268.04%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. NBIG - Yearly Performance Comparison

	2026 (YTD)	2025
CURE Direxion Daily Healthcare Bull 3x Shares	-10.92%	16.46%
NBIG Leverage Shares 2X Long NBIS Daily ETF	487.61%	-62.34%

Correlation

The correlation between CURE and NBIG is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since Oct 28, 2025	0.04

Return for Risk

CURE vs. NBIG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE

CURE Risk / Return Rank: 23
CURE Sharpe Ratio Rank: 22
CURE Sortino Ratio Rank: 25
CURE Omega Ratio Rank: 23
CURE Calmar Ratio Rank: 23
CURE Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. NBIG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Leverage Shares 2X Long NBIS Daily ETF (NBIG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CURE	NBIG	Difference
Sharpe ratio: Return per unit of total volatility	0.72	—	—
Sortino ratio: Return per unit of downside risk	1.33	—	—
Omega ratio: Gain probability vs. loss probability	1.15	—	—
Calmar ratio: Return relative to maximum drawdown	1.02	—	—
Martin ratio: Return relative to average drawdown	2.35	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CURE	NBIG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.72	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.05	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.25	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.47	1.38	-0.91

Drawdowns

CURE vs. NBIG - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum NBIG drawdown of -75.83%. Use the drawdown chart below to compare losses from any high point for CURE and NBIG.

Drawdown Indicators

	CURE	NBIG	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-75.83%	+6.64%
Max Drawdown (1Y) Largest decline over 1 year	-31.10%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	—	—
Current Drawdown Current decline from peak	-29.29%	-3.94%	-25.35%
Average Drawdown Average peak-to-trough decline	-18.15%	-42.82%	+24.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.48%	—	—

Volatility

Volatility by Period

	CURE	NBIG	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.72%	—	—
Volatility (6M) Calculated over the trailing 6-month period	31.07%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	44.12%	200.64%	-156.52%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.88%	200.64%	-156.76%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.58%	200.64%	-151.06%

CURE vs. NBIG - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than NBIG's 0.75% expense ratio.

Dividends

CURE vs. NBIG - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.20%, while NBIG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	1.20%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%
NBIG Leverage Shares 2X Long NBIS Daily ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CURE and NBIG in my portfolio?

CURE and NBIG have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CURE or NBIG?

On fees, NBIG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CURE or NBIG?

NBIG is cheaper with a 0.75% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, CURE or NBIG?

CURE has the higher dividend yield at 1.20%, compared with 0.00% for NBIG.

What is the main difference between CURE and NBIG?

They also come from different issuers: Direxion and Leverage Shares. Their fees differ too: 1.08% for CURE and 0.75% for NBIG.